1891 YEAR FOUNDED
Biopharmaceutical INDUSTRY
74,000 NUMBER OF EMPLOYEES
$ 48bn REVENUE
This can be achieved with technology . The objective is to have a foundational stack with a modular architecture , to join existing networks vs creating our own , depending on geography and aligned strategies .
Zuellig Pharma supports the physical distribution , warehousing and order fulfilment of MSD products in the Asia Pacific region , through blockchain-based solutions . An example of this is the mobile application used in Hong Kong for MSD ’ s Gardasil ® 9 , HPV vaccine . It was created to enable healthcare providers and patients to verify the provenance on a unit level and report suspicious packs and with that help increase safety in a region challenged by counterfeit medicines .
In APAC , MSD and Zuellig Pharma are co-developing and testing a trusted network to which MSD expect will attract more of its Pharma peers . The partnership with distributors and wholesalers adds enormous value to the traceability of pharmaceutical products , without the partnership of Zuellig Pharma or other distributors the final benefit to the customer and patient would be reduced .
16 www . msd . com